- Previous Close
14.62 - Open
14.40 - Bid 13.66 x --
- Ask 13.68 x --
- Day's Range
13.43 - 14.51 - 52 Week Range
9.13 - 16.99 - Volume
6,223,524 - Avg. Volume
5,169,091 - Market Cap (intraday)
2.511B - Beta (5Y Monthly) 0.27
- PE Ratio (TTM)
-- - EPS (TTM)
-0.04 - Earnings Date --
- Forward Dividend & Yield 0.05 (0.34%)
- Ex-Dividend Date Jul 1, 2024
- 1y Target Est
--
Suli Co., Ltd. researches, produces, and sells agrochemicals, flame retardants, pharmaceutical intermediates, and other fine chemicals. The company offers chlorothalonil, azoxystrobin, diflubenzuron, fluazinam, cymoxanil, and boscalid technical products; pesticide formulations; and decabromodiphenyl ethane. It also provides brominated, environment-friendly, and halogen-free flame retardants; and intermediates, including trichloroacetonitrile, tetrachlorophthalonitrile, pentachloropyridine, pentachlorobenzonitrile, isophthalodinitrile, and hydrobromic acid, as well as 1,2-diphenylethane and 1,2-dibromoethane. In addition, the company offers industry biocides, such as Longee 985CHL, 550CCD, 550CC, and 500CHL; and calcium chloride and ferric chloride solution for use in water treatment. It sells its products under the Suli brand name for use in agricultural production, plastics and building materials industries, pharmaceuticals, and other fields in European Union, North America, South America, Africa, Southeast Asia, and other countries. The company was founded in 1994 and is based in Jiangyin, China.
www.suli.comRecent News: 603585.SS
View MorePerformance Overview: 603585.SS
Trailing total returns as of 4/16/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 603585.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 603585.SS
View MoreValuation Measures
Market Cap
2.69B
Enterprise Value
3.15B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.21
Price/Book (mrq)
1.08
Enterprise Value/Revenue
1.49
Enterprise Value/EBITDA
80.90
Financial Highlights
Profitability and Income Statement
Profit Margin
-0.36%
Return on Assets (ttm)
0.01%
Return on Equity (ttm)
-0.39%
Revenue (ttm)
2.12B
Net Income Avi to Common (ttm)
-7.63M
Diluted EPS (ttm)
-0.04
Balance Sheet and Cash Flow
Total Cash (mrq)
837.14M
Total Debt/Equity (mrq)
40.56%
Levered Free Cash Flow (ttm)
-1.14B